Attached files
file | filename |
---|---|
EX-17.1 - EXHIBIT 17.1 - Protea Biosciences Group, Inc. | v387168_ex17-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 18, 2014
PROTEA BIOSCIENCES GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware | 000-51474 | 20-2903252 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) | (IRS Employer Identification No.) |
955 Hartman Run Road
Morgantown, West Virginia 26505
(Address of principal executive offices)(Zip Code)
(304) 292-2226
(Registrant’s telephone number, including area code)
No change
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 18, 2014, Thijs Spoor notified Protea Biosciences Group, Inc. (the “Company”) that he would resign from his position as a member of the board of directors of the Company, effective immediately. Mr. Spoor’s resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Mr. Spoor’s resignation letter is attached as Exhibit 17.1.
Item 9.01 | Exhibits. |
(d) Exhibits
17.1 | Letter of Resignation of Thijs Spoor. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 18, 2014 | PROTEA BIOSCIENCES GROUP, INC. | |
By: | /s/ Stephen Turner | |
Stephen Turner Chief Executive Officer |